Scarica l'app Stockscreener
3.03
24.69%
0.60
Pre-mercato:
2.99
-0.04
-1.32%
Precedente Chiudi:
$2.43
Aprire:
$2.45
Volume 24 ore:
3.26M
Relative Volume:
0.79
Capitalizzazione di mercato:
$32.68M
Reddito:
$144.00K
Utile/perdita netta:
$-14.50M
Rapporto P/E:
-2.0895
EPS:
-1.4501
Flusso di cassa netto:
$-14.95M
1 W Prestazione:
+136.72%
1M Prestazione:
+71.19%
6M Prestazione:
-39.16%
1 anno Prestazione:
-34.42%
Intervallo 1D:
$2.45
$3.16
Intervallo di 1 settimana:
$2.02
$3.29
Portata 52W:
$1.22
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Nome
Serina Therapeutics Inc
Settore
Industria
Telefono
(256) 327-9630
Indirizzo
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
3.03 | 32.68M | 144.00K | -14.50M | -14.95M | -1.4501 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
Serina Therapeutics Inc Borsa (SER) Ultime notizie
Serina Therapeutics POZ Drug Delivery Platform: Technology Overview, Pipeline, and Intellectual Property Portfolio - Minichart
Serina Therapeutics' 2025 net loss widens as R&D expenses jump - TradingView
Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights - marketscreener.com
Parkinson's drug candidate reaches patients as Serina lines up $30M - Stock Titan
Serina Therapeutics (NYSE: SER) posts 2025 loss while funding SER-252 trials - Stock Titan
[10-K] Serina Therapeutics, Inc. Fi... - Stock Titan
Top Executive Makes Notable Move With Serina Therapeutics Stock - TipRanks
Serina Therapeutics CSO Moreadith sells $18,567 in stock By Investing.com - Investing.com Canada
Serina Therapeutics (SER) CSO exercises options then sells 6,500 shares - Stock Titan
Serina Therapeutics Raises Up to $30 Million to Advance SER-252 Parkinson’s Drug Trial and Secures Additional Funding Opportunities - Minichart
Serina Therapeutics to Present at 38th Annual Roth Conference - National Today
Serina Therapeutics to Present at the 38th Annual Roth Conference - Bitget
Serina Therapeutics Inc appoints Greg Bailey as co-chairman of boardSEC filing - marketscreener.com
Serina Therapeutics IncAppoints Greg Bailey As Co-Chairman Of BoardSEC Filing - TradingView
Serina Therapeutics (SER) lines up $30M private placement plus $33.3M warrant upside - Stock Titan
Serina Therapeutics Inc. Faces Stock Volatility Amid Economic Challenges - StocksToTrade
Risk Check: What is the dividend yield of Serina Therapeutics IncEarnings Recap Summary & Daily Profit Focused Stock Screening - baoquankhu1.vn
Serina Therapeutics secures up to $30M in private placement - MSN
Serina Therapeutics Insider Sells $97,500 in Stock - National Today
Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN
Top Serina Therapeutics Executive Makes Notable Stock Move - TipRanks
Serina Therapeutics CSO sells $97,500 in shares By Investing.com - Investing.com Canada
Serina Therapeutics (SER) CSO exercises options and sells 39,000 shares - Stock Titan
Serina Therapeutics Inc. Rallies on Dynamic Market Expansion Prospects - timothysykes.com
Serina Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | 2BO | US81751A1088 - marketscreener.com
Stock Market Today: Futures Drop Ahead Of 'Triple Witching' Session As Iran Threatens 'Zero Restraint'— FedEx, Super Micro In Focus (UPDATED) - Benzinga
Serina Therapeutics (SER) Stock Jumps 39% Following $63M Financing Deal and Leadership Announcement - MEXC
Serina Therapeutics (SER) Stock Climbs 39% on Private Placement and Greg Bailey Appointment - MEXC
Biotech Microcap Rockets After Securing Major Capital Infusion at Premium Valuation - The Globe and Mail
SER Stock Surges Amid Strategic Acquisitions and Partnerships - StocksToTrade
Serina Therapeutics (SER) Stock Soars 39% After Announcing $63M Funding and Leadership Boost - parameter.io
Serina Therapeutics (SER) Stock Soars 39% After $30M Funding Deal and Leadership Boost - MoneyCheck
Serina Therapeutics’ Stock Hits All-Time Low Amid Financial Challenges - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Serina Therapeutics (SER) Stock Surges Over 39% After Hours— Here's Why - Benzinga
Dow Falls Over 300 Points; US Initial Jobless Claims Fall - Sahm
Serina Therapeutics, Inc. Appoints Greg Bailey as Co-Chairman of the Board of Directors - marketscreener.com
Serina Therapeutics Raises $30 Million in Private Placement - marketscreener.com
Parkinson's drug trial gets up to $30M as Serina adds board co-chair - Stock Titan
Macro Review: What is the dividend yield of Serina Therapeutics IncTrade Entry Report & Smart Investment Allocation Insights - baoquankhu1.vn
Serina Therapeutics, Inc. announced that it expects to receive $30 million in funding - marketscreener.com
Aug Swings: Is Serina Therapeutics Inc benefiting from innovation trends2026 Investor Takeaways & High Yield Stock Recommendations - baoquankhu1.vn
Aug Action: Does Serina Therapeutics Inc have declining or rising EPS2026 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
How Serina Therapeutics Inc. stock reacts to inflationary pressuresJuly 2025 Technicals & Low Risk Growth Stock Ideas - Naître et grandir
How Serina Therapeutics Inc. stock benefits from global expansionJuly 2025 Chart Watch & Real-Time Buy Signal Alerts - Naître et grandir
Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors - TipRanks
Entry Recap: Is Zillow Group Inc showing insider buying2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Serina Therapeutics Announces Dosing of First Patient in - GlobeNewswire
New drug SER-252 enters Phase 1b trial for advanced Parkinson's - Stock Titan
SER SEC FilingsSerina Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Serina Therapeutics2026 Funding Rounds & List of Investors - Tracxn
Serina Therapeutics Inc Azioni (SER) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Capitalizzazione:
|
Volume (24 ore):